Abstract:<b>The aim of the study</b> was to develop a methodology for conducting post-registration clinical monitoring of software as a medical device based on artificial intelligence technologies (SaMD-AI).Materials and Methods: The methodology of post-registration clinical monitoring is based on the requirements of regulatory legal acts issued by the Board of the Eurasian Economic Commission. To comply with these requirements, the monitoring involves submission of the review of adverse events reports, the review of developers' routine reports on the safety and efficiency of SaMD-AI, and the assessment of the system for collecting and analyzing developers' post-registration data on the safety and efficiency of medical devices. The methodology was developed with regard to the recommendations of the International Medical Device Regulators Forum and the documents issued by the Food and Drug Administration (USA). Field-testing of this methodology was carried out using SaMD-AI designed for diagnostic imaging.Results: The post-registration monitoring of SaMD-AI consists of three key stages: collecting user feedback, technical monitoring and clinical validation. Technical monitoring involves routine evaluation of SaMD-AI output data quality to detect and remove flaws in a timely manner, and to secure the product stability. Major outcomes include an ordered list of technical flaws in SaMD-AI and their classification using evidence from diagnostic imaging studies. The application of this methodology resulted in a gradual reduction in the number of studies with flaws due to timely improvements in artificial intelligence algorithms: the number of flaws decreased to 5% in various aspects during subsequent testing. Clinical validation confirmed that SaMD-AI is capable of producing clinically meaningful outputs related to its intended use within the functionality determined by the developer. The testing procedure and the baseline testing framework were established during the field testing.Conclusion: The developed methodology will ensure the safety and efficiency of SaMD-AI taking into account its specifics as intangible medical devices. The methodology presented in this paper can be used by SaMD-AI developers to plan and carry out the post-registration clinical monitoring.

A Study On The Function Of Medical Device Postmarket Monitoring Technical System In China

Comparative Study on Monitoring System of Medical Device Adverse Events in America, European Union and China

[Research on the issues in the process of post-market surveillance for medical devices based on the typical case analysis]

The current situation and development of medical device testing institutes in China

The Enlightenment of the Management of EU Notified Bodies to China's Introduction of Third-Party Institutions for Medical Device Supervision

Technical specifications for hospital-based intensive monitoring of post-marketing Chinese patent medicine

[Analysis on Evaluation of Medical Device Adverse Events Monitoring and Some Factors Influencing MDAE's Reporting by Medical Personnels].

Supervision System of AI-based Software As a Medical Device

The Current Problems of Regulation of Medical Devices and Countermeasures

Development Trends of the Post-Marketing Drug Safety Surveillance Systems in EU and US

[Better medical devices regulations for better health care: enlightenment for medical devices regulatory reform in China, from experiences of the E.U. and the U.S.A]

Study on Construction and Development of Primary Adverse Drug Reaction Monitoring System in China

Monitoring Evaluation and Results Analysis of High-Risk Medical Equipment

[Analysis of the current situation of production supervision of medical devices in China]

Application of Medical Safety Monitoring System in Health Supervision

The Brief Introduction to the Researh on the Monitoring System Medical Safety

[Study on the reform and improvement of the medical device registration system in China].

Studv on the Current Situation of Allocation and Utilization of Major Medical Equipment in China and Relevant Policy Suggestions

Policy Review and Problem Analysis of Major Medical Equipment (class B) Allocation and Management in China

The present situation and prospect in post-marketing surveillance of drug safety

Methodology for Conducting Post-Marketing Surveillance of Software as a Medical Device Based on Artificial Intelligence Technologies